DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.088
EU - Europa 7.052
AS - Asia 3.084
OC - Oceania 38
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 8
Totale 33.317
Nazione #
US - Stati Uniti d'America 23.052
CN - Cina 1.948
DE - Germania 1.937
UA - Ucraina 1.570
IT - Italia 1.217
TR - Turchia 977
GB - Regno Unito 672
FI - Finlandia 366
SE - Svezia 356
RU - Federazione Russa 333
PL - Polonia 235
BE - Belgio 164
FR - Francia 82
VN - Vietnam 55
AU - Australia 32
CA - Canada 29
RO - Romania 21
IE - Irlanda 20
IR - Iran 20
BR - Brasile 19
IN - India 18
JP - Giappone 15
ES - Italia 13
CH - Svizzera 11
EU - Europa 11
NL - Olanda 11
KR - Corea 8
GR - Grecia 7
HK - Hong Kong 7
MX - Messico 7
CZ - Repubblica Ceca 6
IL - Israele 6
IQ - Iraq 6
NZ - Nuova Zelanda 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
EG - Egitto 5
ID - Indonesia 5
AR - Argentina 4
BG - Bulgaria 4
LU - Lussemburgo 4
MD - Moldavia 4
AM - Armenia 3
CO - Colombia 3
DK - Danimarca 3
EE - Estonia 3
PT - Portogallo 3
TW - Taiwan 3
AT - Austria 2
CL - Cile 2
EC - Ecuador 2
LT - Lituania 2
SA - Arabia Saudita 2
BN - Brunei Darussalam 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 33.317
Città #
Fairfield 3.203
Woodbridge 3.021
Houston 2.102
Jacksonville 1.820
Chandler 1.734
Ann Arbor 1.583
Ashburn 1.230
Wilmington 1.196
Seattle 1.142
Cambridge 937
Izmir 684
Nanjing 529
Ferrara 482
Princeton 440
Beijing 359
San Diego 289
Boardman 285
Warsaw 221
Addison 209
Brussels 161
Nanchang 150
Shenyang 146
Dearborn 134
Milan 133
Bremen 115
Hebei 107
Tianjin 99
Jiaxing 96
Redwood City 86
Changsha 75
Mountain View 68
Norwalk 67
London 62
Falls Church 57
Dong Ket 54
Zhengzhou 52
Jinan 50
San Mateo 48
Kunming 41
Ningbo 39
Guangzhou 37
Orange 35
Auburn Hills 32
Helsinki 32
Des Moines 30
Indiana 30
Chicago 27
Augusta 26
Los Angeles 26
Tappahannock 26
Washington 25
Rome 24
Taizhou 24
Philadelphia 23
Hangzhou 22
Verona 20
Shanghai 19
Padova 18
Redmond 18
Bologna 17
New York 17
Lanzhou 16
Monmouth Junction 16
Haikou 14
Munich 14
Leawood 13
Montréal 10
Rovereto 10
Changchun 9
Ferrara di Monte Baldo 9
Hounslow 9
San Francisco 9
Ardabil 8
Catania 8
Chiswick 8
Hefei 8
Napoli 8
Walnut 8
Acton 7
Dublin 7
Ottawa 7
Berkeley 6
Calvisano 6
Fuzhou 6
Islington 6
Menlo Park 6
Prescot 6
Saint Albans 6
Salerno 6
Sheffield 6
Andover 5
Bozeman 5
Chengdu 5
Edinburgh 5
Palermo 5
Sydney 5
São Paulo 5
Trento 5
Vancouver 5
Vicenza 5
Totale 24.136
Nome #
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 294
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 201
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 201
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 171
P2X7 targeting inhibits growth of human mesothelioma 168
IL PROCESSO INFIAMMATORIO 164
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. 157
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 154
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 148
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 147
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP 146
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 144
Purinergic signaling in the immune system 140
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 137
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 134
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 134
Role of P2X7 receptor in host response to melanoma 134
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 132
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 132
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 132
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 131
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 130
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 126
The antibiotic polymyxin B modulates P2X7 receptor function 126
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 126
The P2X7 receptor is a key modulator of aerobic glycolysis. 125
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 125
The P2X7 receptor: a key player in IL-1 processing and release 125
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 125
Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase 124
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis 123
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 122
The P2X7 receptor-interleukin-1 liaison 122
Expression of P2X7 receptor increases in vivo tumor growth 122
Purinoceptor function in the immune system 121
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors 121
Insight on P2X7 receptor role as oncogene 120
P2 receptors in cancer progression and metastatic spreading 120
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity 119
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 119
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 119
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 119
ATP-mediated cytotoxicity in microglial cells 117
The antibiotic polymyxin B modulates P2X7 receptor function 117
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 116
Purinergic regulation of airway inflammation 115
Activation of muscarinic receptors in PC12 cells. Correlation between cytosolic Ca2+ rise and phosphoinositide hydrolysis. 115
null 115
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 114
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 113
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 112
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 112
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 112
null 111
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 111
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 111
null 111
Extracellular nucleotides and nucleosides as signalling molecules 110
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 109
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 109
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 108
Activation of muscarinic receptors in PC12 cells. Stimulation of Ca2+ influx and redistribution. 108
Sidedness of e− Donation and Stoichiometry of H+ Pumps at Sites II + III in Mitochondria from Rat Liver 108
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease 108
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells 107
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 107
P2 purinoceptors in the immune system 107
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 106
Role of the P2X7 receptor in tumor-associated inflammation 106
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor containing a tyrosine moiety 105
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 105
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production 105
Cell-mediated cytotoxicity: ATP as an effector and the role of target cells 105
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 105
The P2X7 receptor : from ion channel to oncogene 105
The P2X7 Receptor in Infection and Inflammation 105
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 105
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 104
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. 104
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 104
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. 104
Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. 104
The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner 104
The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release 103
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes 103
null 103
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 103
P2X7 receptor and polykarion formation 102
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling 102
Dysfunctional inflammasome in Schnitzler's syndrome 102
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 102
Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive p2y receptors 101
Purinergic signalling between axons and microglia 101
Effect of cytochalasins on cytosolic-free calcium concentration and phosphoinositide metabolism in leukocytes 101
H+/site, charge/site, and ATP/site ratios in mitochondrial electron transport. 101
P2X receptors and inflammation 101
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 101
Molecular machinery and signaling events in apoptosis 101
Extracellular ATP activates transcription factor NFAT in mouse microglial cells 101
Reduced loading of intracellular Ca2+ stores and downregulation of capacitative Ca2+ influx in Bcl-2-overexpressing cells 100
Totale 12.067
Categoria #
all - tutte 102.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.223
Totale 104.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.795 0 0 0 0 128 83 607 34 410 814 930 1.789
2019/20207.338 1.202 245 229 1.077 501 903 650 774 608 672 309 168
2020/20215.219 456 430 229 569 286 526 222 595 199 650 700 357
2021/20224.486 122 466 258 157 278 213 236 245 197 355 433 1.526
2022/20234.223 484 173 139 487 684 597 142 461 546 69 297 144
2023/2024931 245 329 97 77 183 0 0 0 0 0 0 0
Totale 33.961